How to treat lymphedema after breast cancer surgery

How to treat lymphedema after breast cancer surgery?

The treatment methods for upper limb lymphedema after breast cancer surgery are as follows: Non-surgical method: Suitable for early mild cases. The principle is to improve local microcirculation through physical heat energy and mechanical pressure, promote lymphatic return, reduce and prevent fibrous tissue hyperplasia, and delay and improve the progression of the disease.

Lymphedema after breast cancer surgery is basically due to the removal of the affected breast and lymph node cleaning, which leads to lymphatic reflux obstruction and lymphedema in the affected upper limb. This edema is basically manifested as edema of the upper limb and the affected side. Many breast cancer patients will experience edema in the affected limb after surgery, which is actually more troublesome.

What does invasive breast cancer mean?

It is best to go to the hospital immediately for radiotherapy and chemotherapy, which will have better effects and can inhibit the continued growth and spread of cancer cells. Actively cooperate with the doctor's treatment to reduce damage to life. Chemotherapy may bring side effects to the body. Invasive breast cancer refers to a malignant tumor disease in which breast cancer cells invade the local stroma. Patients will experience symptoms such as local lumps, overflow, and skin depressions.

Disease diagnosis: Infiltrative breast cancer refers to a malignant tumor that occurs in the breast, in which cancer cells penetrate the basement membrane of the glandular duct or lobular alveoli and invade the stroma.

How long is the survival rate for advanced breast cancer?

The survival period of patients with advanced breast cancer is generally 1-3 years, but it varies from person to person and is affected by many factors. However, for multiple systemic metastases, the overall prognosis is relatively poor, and systemic drug therapy needs to be considered, mainly chemotherapy, which can be combined with targeted drugs and immune agents for treatment. For the survival period of advanced breast cancer.